世界の抗糖尿病市場予測2021-2027:1型糖尿病、2型糖尿病、その他

Market Monitor Globalが発行した調査報告書(MMG21DC17239)
◆英語タイトル:Antidiabetics Market - Global Outlook and Forecast 2021-2027
◆商品コード:MMG21DC17239
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2021年12月(※2024年版があります。お問い合わせください。)
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Monitor Global社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

Market Monitor Global社が発行した本調査レポートは、世界の抗糖尿病市場について調査し取りまとめました。抗糖尿病の世界市場規模(2016年-2027年)、市場予測、企業別市場シェア、種類別分析(1型糖尿病、2型糖尿病、その他)、用途別分析(病院、クリニック、家庭、その他)、地域別分析(北米、アメリカ、カナダ、メキシコ、ヨーロッパ、ドイツ、フランス、イギリス、アジア、中国、日本、韓国、東南アジア、インド、南米、ブラジル、中東、アフリカなど)、関連メーカーの概要、市場動向・機会・成長・阻害要因、サプライチェーンなどの情報をお届けいたします。
・世界の抗糖尿病市場規模2021年vs2027年
・世界の抗糖尿病市場:売上予測2016年-2027年
・主要企業別の抗糖尿病売上・市場シェア・価格
・抗糖尿病の種類別市場規模:1型糖尿病、2型糖尿病、その他
・抗糖尿病の用途別市場規模:病院、クリニック、家庭、その他
・地域別市場規模
・抗糖尿病の北米市場:アメリカ市場、カナダ市場、メキシコ市場
・抗糖尿病のヨーロッパ市場:ドイツ市場、フランス市場、イギリス市場など
・抗糖尿病のアジア市場:中国市場、日本市場、韓国市場、東南アジア市場など
・抗糖尿病の南米市場:ブラジル市場、アルゼンチン市場など
・抗糖尿病の中東・アフリカ市場:トルコ市場、サウジアラビア市場、UAE市場など
・主要メーカー及びブランド概要:Sanofi-Aventis、Takeda Pharmaceuticals、Eli Lilly、Oramed Pharmaceuticals、Boehringer Ingelheim、Merck & Co. Inc.、Novo Nordisk、Bristol-Myers Squibb、Halozyme Therapeutics、Pfizer
・世界の抗糖尿病の生産能力2016年-2027年
・市場動向・機会・成長・阻害要因分析
・抗糖尿病のサプライチェーン分析
・調査の結論
【レポートの概要】

This report contains market size and forecasts of Antidiabetics in global, including the following market information:
Global Antidiabetics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Antidiabetics Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Antidiabetics companies in 2020 (%)
The global Antidiabetics market was valued at 59860 million in 2020 and is projected to reach US$ 73950 million by 2027, at a CAGR of 5.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antidiabetics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antidiabetics Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Antidiabetics Market Segment Percentages, By Type, 2020 (%)
Type 1 Diabetes
Type 2 Diabetes
Other

Global Antidiabetics Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Antidiabetics Market Segment Percentages, By Application, 2020 (%)
Hospital Use
Clinic Use
Household
Other

Global Antidiabetics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Antidiabetics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antidiabetics revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Antidiabetics revenues share in global market, 2020 (%)
Key companies Antidiabetics sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Antidiabetics sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi-Aventis
Takeda Pharmaceuticals
Eli Lilly
Oramed Pharmaceuticals
Boehringer Ingelheim
Merck & Co. Inc.
Novo Nordisk
Bristol-Myers Squibb
Halozyme Therapeutics
Pfizer

【レポートの目次】

1 Introduction to Research & Analysis Reports
1.1 Antidiabetics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antidiabetics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antidiabetics Overall Market Size
2.1 Global Antidiabetics Market Size: 2021 VS 2027
2.2 Global Antidiabetics Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Antidiabetics Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Antidiabetics Players in Global Market
3.2 Top Global Antidiabetics Companies Ranked by Revenue
3.3 Global Antidiabetics Revenue by Companies
3.4 Global Antidiabetics Sales by Companies
3.5 Global Antidiabetics Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antidiabetics Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Antidiabetics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antidiabetics Players in Global Market
3.8.1 List of Global Tier 1 Antidiabetics Companies
3.8.2 List of Global Tier 2 and Tier 3 Antidiabetics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Antidiabetics Market Size Markets, 2021 & 2027
4.1.2 Type 1 Diabetes
4.1.3 Type 2 Diabetes
4.1.4 Other
4.2 By Type – Global Antidiabetics Revenue & Forecasts
4.2.1 By Type – Global Antidiabetics Revenue, 2016-2021
4.2.2 By Type – Global Antidiabetics Revenue, 2022-2027
4.2.3 By Type – Global Antidiabetics Revenue Market Share, 2016-2027
4.3 By Type – Global Antidiabetics Sales & Forecasts
4.3.1 By Type – Global Antidiabetics Sales, 2016-2021
4.3.2 By Type – Global Antidiabetics Sales, 2022-2027
4.3.3 By Type – Global Antidiabetics Sales Market Share, 2016-2027
4.4 By Type – Global Antidiabetics Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antidiabetics Market Size, 2021 & 2027
5.1.2 Hospital Use
5.1.3 Clinic Use
5.1.4 Household
5.1.5 Other
5.2 By Application – Global Antidiabetics Revenue & Forecasts
5.2.1 By Application – Global Antidiabetics Revenue, 2016-2021
5.2.2 By Application – Global Antidiabetics Revenue, 2022-2027
5.2.3 By Application – Global Antidiabetics Revenue Market Share, 2016-2027
5.3 By Application – Global Antidiabetics Sales & Forecasts
5.3.1 By Application – Global Antidiabetics Sales, 2016-2021
5.3.2 By Application – Global Antidiabetics Sales, 2022-2027
5.3.3 By Application – Global Antidiabetics Sales Market Share, 2016-2027
5.4 By Application – Global Antidiabetics Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region – Global Antidiabetics Market Size, 2021 & 2027
6.2 By Region – Global Antidiabetics Revenue & Forecasts
6.2.1 By Region – Global Antidiabetics Revenue, 2016-2021
6.2.2 By Region – Global Antidiabetics Revenue, 2022-2027
6.2.3 By Region – Global Antidiabetics Revenue Market Share, 2016-2027
6.3 By Region – Global Antidiabetics Sales & Forecasts
6.3.1 By Region – Global Antidiabetics Sales, 2016-2021
6.3.2 By Region – Global Antidiabetics Sales, 2022-2027
6.3.3 By Region – Global Antidiabetics Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country – North America Antidiabetics Revenue, 2016-2027
6.4.2 By Country – North America Antidiabetics Sales, 2016-2027
6.4.3 US Antidiabetics Market Size, 2016-2027
6.4.4 Canada Antidiabetics Market Size, 2016-2027
6.4.5 Mexico Antidiabetics Market Size, 2016-2027
6.5 Europe
6.5.1 By Country – Europe Antidiabetics Revenue, 2016-2027
6.5.2 By Country – Europe Antidiabetics Sales, 2016-2027
6.5.3 Germany Antidiabetics Market Size, 2016-2027
6.5.4 France Antidiabetics Market Size, 2016-2027
6.5.5 U.K. Antidiabetics Market Size, 2016-2027
6.5.6 Italy Antidiabetics Market Size, 2016-2027
6.5.7 Russia Antidiabetics Market Size, 2016-2027
6.5.8 Nordic Countries Antidiabetics Market Size, 2016-2027
6.5.9 Benelux Antidiabetics Market Size, 2016-2027
6.6 Asia
6.6.1 By Region – Asia Antidiabetics Revenue, 2016-2027
6.6.2 By Region – Asia Antidiabetics Sales, 2016-2027
6.6.3 China Antidiabetics Market Size, 2016-2027
6.6.4 Japan Antidiabetics Market Size, 2016-2027
6.6.5 South Korea Antidiabetics Market Size, 2016-2027
6.6.6 Southeast Asia Antidiabetics Market Size, 2016-2027
6.6.7 India Antidiabetics Market Size, 2016-2027
6.7 South America
6.7.1 By Country – South America Antidiabetics Revenue, 2016-2027
6.7.2 By Country – South America Antidiabetics Sales, 2016-2027
6.7.3 Brazil Antidiabetics Market Size, 2016-2027
6.7.4 Argentina Antidiabetics Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Antidiabetics Revenue, 2016-2027
6.8.2 By Country – Middle East & Africa Antidiabetics Sales, 2016-2027
6.8.3 Turkey Antidiabetics Market Size, 2016-2027
6.8.4 Israel Antidiabetics Market Size, 2016-2027
6.8.5 Saudi Arabia Antidiabetics Market Size, 2016-2027
6.8.6 UAE Antidiabetics Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Corporate Summary
7.1.2 Sanofi-Aventis Business Overview
7.1.3 Sanofi-Aventis Antidiabetics Major Product Offerings
7.1.4 Sanofi-Aventis Antidiabetics Sales and Revenue in Global (2016-2021)
7.1.5 Sanofi-Aventis Key News
7.2 Takeda Pharmaceuticals
7.2.1 Takeda Pharmaceuticals Corporate Summary
7.2.2 Takeda Pharmaceuticals Business Overview
7.2.3 Takeda Pharmaceuticals Antidiabetics Major Product Offerings
7.2.4 Takeda Pharmaceuticals Antidiabetics Sales and Revenue in Global (2016-2021)
7.2.5 Takeda Pharmaceuticals Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Antidiabetics Major Product Offerings
7.3.4 Eli Lilly Antidiabetics Sales and Revenue in Global (2016-2021)
7.3.5 Eli Lilly Key News
7.4 Oramed Pharmaceuticals
7.4.1 Oramed Pharmaceuticals Corporate Summary
7.4.2 Oramed Pharmaceuticals Business Overview
7.4.3 Oramed Pharmaceuticals Antidiabetics Major Product Offerings
7.4.4 Oramed Pharmaceuticals Antidiabetics Sales and Revenue in Global (2016-2021)
7.4.5 Oramed Pharmaceuticals Key News
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Corporate Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Antidiabetics Major Product Offerings
7.5.4 Boehringer Ingelheim Antidiabetics Sales and Revenue in Global (2016-2021)
7.5.5 Boehringer Ingelheim Key News
7.6 Merck & Co. Inc.
7.6.1 Merck & Co. Inc. Corporate Summary
7.6.2 Merck & Co. Inc. Business Overview
7.6.3 Merck & Co. Inc. Antidiabetics Major Product Offerings
7.6.4 Merck & Co. Inc. Antidiabetics Sales and Revenue in Global (2016-2021)
7.6.5 Merck & Co. Inc. Key News
7.7 Novo Nordisk
7.7.1 Novo Nordisk Corporate Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Antidiabetics Major Product Offerings
7.4.4 Novo Nordisk Antidiabetics Sales and Revenue in Global (2016-2021)
7.7.5 Novo Nordisk Key News
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporate Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Antidiabetics Major Product Offerings
7.8.4 Bristol-Myers Squibb Antidiabetics Sales and Revenue in Global (2016-2021)
7.8.5 Bristol-Myers Squibb Key News
7.9 Halozyme Therapeutics
7.9.1 Halozyme Therapeutics Corporate Summary
7.9.2 Halozyme Therapeutics Business Overview
7.9.3 Halozyme Therapeutics Antidiabetics Major Product Offerings
7.9.4 Halozyme Therapeutics Antidiabetics Sales and Revenue in Global (2016-2021)
7.9.5 Halozyme Therapeutics Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Antidiabetics Major Product Offerings
7.10.4 Pfizer Antidiabetics Sales and Revenue in Global (2016-2021)
7.10.5 Pfizer Key News
8 Global Antidiabetics Production Capacity, Analysis
8.1 Global Antidiabetics Production Capacity, 2016-2027
8.2 Antidiabetics Production Capacity of Key Manufacturers in Global Market
8.3 Global Antidiabetics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antidiabetics Supply Chain Analysis
10.1 Antidiabetics Industry Value Chain
10.2 Antidiabetics Upstream Market
10.3 Antidiabetics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antidiabetics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

...

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の抗糖尿病市場予測2021-2027:1型糖尿病、2型糖尿病、その他(Antidiabetics Market - Global Outlook and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆